ABC | Volume 112, Nº3, Março 2019

Atualização Atualização da Diretriz em Cardiologia do Esporte e do Exercício da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Medicina do Exercício e Esporte – 2019 Arq Bras Cardiol. 2019; 112(3):326-368 118. Tsatsopoulou A. Arrhythmogenic right ventricular cardiomyopathy and pregnancy. Int J Cardiol. 2018May 1;258:199-200. 119. Wang W, James CA, Calkins H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. Europace. 2018 Apr 23. [Epub ahead of print]. 120. Calkins H, Corrado D, Marcus F. Risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation. 2017;136(21):2068-82. 121. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61-72. 122. Tsatsopoulou A, Bossone E. Common presentation of rare diseases: arrhythmogenic right ventricular cardiomyopathy and its mimics. Int J Cardiol. 2018 Apr 15;257:371-7. 123. Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Farhan M, et al. ImportanceofCMRwithintheTaskForceCriteria forthediagnosisofARVC in children and adolescents. J AmColl Cardiol. 2015;65(10):987-95. 124. Zaidi A, Sheikh N, Jongman JK, Gati S, Panoulas VF, Carr-White G. Clinical differentiation between physiological remodeling and arrhythmogenic right ventricular cardiomyopathy in athletes with marked electrocardiographic repolarization anomalies. J AmColl Cardiol. 2015;65(25):2702-11. 125. Paul M, Meyborg M, Boknik P, Gergs U, Gerss J, Schmitz W, et al. Autonomic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: biochemical evidence of altered signaling pathways. Pacing Clin Electrophysiol. 2014;37(2):173-8. 126. LaGercheA.Definingtheinteractionbetweenexerciseandarrhythmogenic right ventricular cardiomyopathy. Eur J Heart Fail. 2015;17(2):128-31. 127. Haugaa KH, Bundgaard H, Edvardsen T, Eschen O, Gilljam T, Hansen J, et al. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries. Scand Cardiovasc J. 2015;49(6):299-307. 128. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J AmColl Cardiol. 2013;62(14):1290-7. 129. Wang W, Orgeron G, Tichnell C, Murray B, Crosson J, Monfredi O, et al. Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy. J Am Heart Assoc. 2018;7(12). pii: e008843. 130. Lie OH, Dejgaard LA, Saberniak J, Rootwelt C, Stokke MK, Edvardsen T, et al. Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol. 2018;4(6):744-53. 131. Shah N, Phelan DM. Myocarditis in the athlete. AmColl Cardiol. 2018 Jan 31. [Epub ahead of print]. 132. TrachtenbergBH,HareJM.Inflammatorycardiomyopathicsyndromes.Circ Res. 2017;121(7):803-18. 133. Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J AmColl Cardiol. 2013;61(10):1027-40. 134. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48. 135. SagarS,LiuPP,CooperLTJr.Myocarditis.Lancet.2012;379(9817):738-47. 136. Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, BohmM. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13(4):398-405 137. Zorzi A, Pelliccia A, Corrado D. Inherited cardiomyopathies and sports participation. Neth Heart J. 2018;26(3):154-65. 138. WeintraubRG,SemsarianC,MacdonaldP.Dilatedcardiomyopathy.Lancet. 2017;390(10092):400-14. 139. McNallyEM,MestroniL.Dilatedcardiomyopathy:geneticdeterminantsand mechanisms. Circ Res. 2017;121(7):731-48. 140. Pi SH, Kim SM, Choi JO, Kim EK, Chang SA, Choe YH, et al. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilatedcardiomyopathywithmoderatetoseverelyreducedejectionfraction. J CardiovascMagn Reson. 2018;20(1):36. 141. Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228-39. 142. Asif IM, Harmon KG. Incidence and etiology of sudden cardiac death: new updates for athletic departments. Sports Health. 2017;9(3):268-79. 143. Asatryan B, Vital C, Kellerhals C, Medeiros-Domingo A, Gräni C, Trachsel LD, et al. Sports-related sudden cardiac deaths in the young population of Switzerland. PLoSOne. 2017;12(3):e0174434. 144. Emery MS, Kovacs RJ. Sudden cardiac death in athletes. JACC Heart Fail. 2018;6(1):30-40. 145. Herdy AH, Lopez-Jimenez F, Terzic CP, Milani M, Stein R, Carvalho T, et al; Sociedade Brasileira de Cardiologia. South American Guidelines for Cardiovascular Disease Prevention and Rehabilitation. Arq Bras Cardiol. 2014;103(2 Supl.1):1-31. 146. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015;386(9995):813-25. 147. Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy. Eur Heart J. 2017;38(46):3449-60. 148. Hotta VT, Tendolo SC, Rodrigues AC, Fernandes F, Nastari L, Mady C. Limitations in the diagnosis of noncompaction cardiomyopathy by echocardiography. Arq Bras Cardiol. 2017;109(5):483-8. 149. Finsterer J, Stöllberger C, Towbin JA. Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors. Nat Rev Cardiol. 2017;14(4):224-37. 150. Thavendiranathan P, Dahiya A, Phelan D, Desai MY, Tang WH. Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes andmanagement. Heart. 2013;99(10):681-9. 151. Ganga HV, Thompson PD. Sports participation in non-compaction card iomyopathy:asystematicreview.BrJSportsMed. 2014;48(20):1466-71. 152. Coris EE, Moran BK, De Cuba R, Farrar T, Curtis AB. Left ventricular non- compaction inathletes:toplayornottoplay.SportsMed. 2016;46(9):1249-59. 153. GatiS,ChandraN,BennettRL,ReedM,KervioG,PanoulasVF,etal.Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99(6):401-8. Erratum in: Heart. 2013;99(7):506. 154. Caselli S, Ferreira D, Kanawati E, Di Paolo F, Pisicchio C, Attenhofer Jost C, et al.Prominentleftventriculartrabeculationsincompetitiveathletes:aproposal forriskstratificationandmanagement.IntJCardiol.2016Nov15;223:590-5. 155. Monge-Maillo B, López-Vélez R. Challenges in the management of Chagas disease in Latin-American migrants in Europe. Clin Microbiol Infect. 2017;23(5):290-5. 156. Cucunubá ZM, Okuwoga O, Basáñez MG, Nouvellet P. Increased mortality attributed to Chagas disease: a systematic review and meta-analysis. Parasit Vectors. 2016 Jan 27;9:42. 157. Traina MI, Hernandez S, Sanchez DR, Dufani J, Salih M, Abuhamidah AM, et al. Prevalence of Chagas Disease in a U.S. population of Latin American immigrantswithconductionabnormalitiesonelectrocardiogram.PLoSNegl TropDis. 2017;11(1):e0005244. 158. Merejo Peña CM, Reis MS, Pereira BB, Nascimento EM, Pedrosa RC. Dysautonomy in different death risk groups (Rassi score) in patients with Chagas heart disease. Pacing Clin Electrophysiol. 2018;41(3):238-45. 159. Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al. The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25(1):75-83. 364